The 12 closest competitors and alternatives to Phylos Bioscience, Inc. among biotechnology companies — ranked by similarity to what Phylos Bioscience, Inc. actually does, not by market-cap band.
Subscribe to see Phylos Bioscience, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Phylos Bioscience, Inc. is a cannabis genetics company that empowers growers of all sizes. The firm provides production-ready seeds and leverages plant genetics to support the cannabis industry.
Phylos Bioscience, Inc. is a biotechnology company headquartered in United States. It has raised at least $50.5M across the 10 funding rounds on record, 8 of them with a disclosed amount. Its most recent funding round, Series B, raised $583,418 in December 2025. Xcout tracks 14 named people at Phylos Bioscience, Inc., including Barbara A Peachey (Chief Financial Officer).
8 more named people on record for Phylos Bioscience, Inc., with roles, board committees and tenure — see the full roster →
At least $50.5M raised across the 10 rounds on record (8 with a disclosed amount). The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $583,418 | 2 named | |
| SEC Form D filing | $1.8M | — | |
| SEC Form D filing | $150,000 | — | |
| Debt | Undisclosed | 1 named | |
| SEC Form D filing | $250,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Phylos Bioscience, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Outlier BioPharma Inc. is a vertically integrated biotechnology company that provides cultivation, extraction, research and development, and global distribution services for cannabis and cannabinoid-based products. The company serves partners in the cannabis industry by offering turn-key contract processing, private-label manufacturing, genetics development, and wholesale distribution.
Agricultural Biotechnology
Front Range Biosciences, Inc. is an agricultural biotechnology company focused on providing high-value crops and advanced breeding solutions for the agricultural and horticultural markets.
Similar biotechnology company
Phyto Teq, Inc. (PhytoTech Labs) manufactures and supplies plant tissue culture media, biochemicals, and laboratory equipment. The company serves research laboratories, commercial growers, and global tissue culture facilities with standardized and custom formulations.
Biotech
Pharmagreen Biotech Inc. is a biotechnology solutions provider primarily engaged in cultivating young plant stock for the medical cannabis and CBD hemp industries. Established in 2007, the company operates from its base in Coquitlam, Canada.
Similar biotechnology company
Bakhu Holdings, Corp. provides cannabis biotechnology and plant cell replication technology for cultivators and partners. The company utilizes patented laboratory processes to enable plants to self-produce on a cellular level, aiming to improve cultivation yield, quality, and cost efficiency compared to traditional methods.
Biotech
Ohalo Genetics, Inc. is an agricultural biotechnology company that develops novel breeding systems and improved plant varieties using technologies such as Boosted Breeding and Agile Breeding. The company's technology aims to shorten plant breeding cycles, helping farmers increase crop yields while using fewer natural resources across multiple crops.
Similar biotechnology company
Plastomics Inc. is an early-stage plant biotechnology company based in St. Louis, Missouri, developing next-generation trait delivery technology through a novel chloroplast system to create safer and more effective crops.
Similar biotechnology company
Day Three Labs Inc. is a biotechnology and pharmaceutical formulation company based in Denver, Colorado, founded in 2021. The company specializes in nanodelivery technologies that enhance the bioavailability of cannabinoid and pharmaceutical compounds.
Biotech
Avicanna Inc., a biopharmaceutical firm headquartered in Toronto, Canada, and founded in 2016, is actively engaged in the research, development, and commercialization of scientifically validated products for both global medical and consumer health markets. The company's comprehensive scientific framework encompasses R&D and clinical trials, often undertaken in collaboration with Canadian academic and medical institutions. This effort has yielded around twenty commercialized products spanning four primary market categories. These offerings include medical and wellness items under the RHO Phyto brand, featuring cannabinoids such as CBD, CBG, and THC; CBD-infused topical and derma-cosmetic products marketed under the Pura H&W and Pura Earth labels; and bulk cannabis and hemp-derived raw materials like dried flowers, standardized seeds, full-spectrum extracts, cannabinoid distillates, and isolates, provided through the Aureus brand. Additionally, Avicanna is advancing a pharmaceutical pipeline focused on treatments for conditions including epidermolysis bullosa, dermatological ailments, chronic pain, and various neurological disorders. A notable research partnership with Dr. Christine Allen's Research Group is dedicated to developing a cannabinoid-based therapy for lung inflammation linked to COVID-19.
Similar biotechnology company
Green-Agr Biotechnology develops and distributes natural, organic bio-solutions derived from plant hormones, polysaccharides, and peptides to enhance agricultural crop yields and plant health. The company serves agricultural producers, growers, and farmers across sectors such as citrus, tree fruits, vegetables, nuts, and turf by providing chemical-free formulations that maximize genetic potential and disease tolerance.
Biotechnology Research
Biolux Research Holdings, Inc. supplies research-grade compounds and peptides in lyophilized powder form strictly for laboratory and scientific use. The company serves qualified researchers and licensed professionals by providing tested formulations intended for controlled research environments rather than human consumption or clinical applications.
Similar biotechnology company
Auxergen develops and sells innovative biologic solutions and biocontrol treatments, such as XylePhage, to target diseases affecting humans, plants, and the environment. The company focuses on reducing the reliance on chemical pesticides in agriculture to promote soil, watershed, and environmental health.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Phylos Bioscience, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →